Price $3.73 |
Market Cap
368.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
5.27
|
P/S
0.92
|
Dividend %
-
|
|
P/CF
46.9
|
P/FCF
10.2
|
Op. Cash Flow
38.5K
|
FCF
0.3
|
|
Op. Margin
3.10%
|
Net Margin
-1.60%
|
ROE
-8.60%
|
ROI
4.30%
|
|
ROA
-1.30%
|
EPS Growth
-265.40%
|
Current Ratio
1.8
|
Debt/Equity
247.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Lantheus Holdings Inc (LNTH) | $25.60 | - | - | 1.83B | Strong Buy |
| Concert Pharmaceuticals Inc (CNCE) | $3.71 | - | - | 121M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $2.80 | - | - | 41.2M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $8.99 | - | - | 10.34B | Strong Buy |
| Endo International PLC (ENDP) | $2.83 | - | - | 499.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
